Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
70 hedge funds and large institutions have $69.2M invested in Amicus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
401% more call options, than puts
Call options by funds: $1.66M | Put options by funds: $331K
Top Buyers
Top Sellers
FOLD Hedge Fund Activity: Q2 2013 in Review
70 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q2 2013, worth a combined $69.2M.
Buyers outnumbered sellers: 70 funds opened new FOLD positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.
- 70 institutional investors held Amicus Therapeutics (FOLD) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $69.2M of Amicus Therapeutics stock for Q2 2013.
- 70 funds opened new Amicus Therapeutics positions in Q2 2013 and 0 closed out, a net change of +70 holders.
Based on aggregated 13F filings for Q2 2013.